Autopsy report · NCT04228276

Treating Stimulant Addiction With Repetitive Transcranial Magnetic Stimulation

“COVID-19 pandemic adversely affected recruitment.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 1 month before it started.
• Ran for about 3 years 4 months before it stopped.
• 30 participants enrolled.
• Results were posted on the registry 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

VA Office of Research and Development

Sponsor type

US federal agency

Conditions

Stimulant Use Disorder; Substance-related Disorders

Interventions

Repetitive transcranial magnetic stimulation (rTMS)

Participants

30

Sites

1

Countries

United States

Trials that died the same way

• Sleep, Insulin Sensitivity, and Weight in Adolescents Post-bariatric Surgery
  “COVID-19 pandemic impacted recruitment” (95% match in meaning)
• Laser Treatment for Vulvar Lichen Sclerosus
  “Recruitment was significantly impacted by the COVID-19 pandemic.” (95% match in meaning)
• Pathology and Imaging in Kidney Allografts
  “recruitment difficulties due to impact of COVID-19 pandemic” (91% match in meaning)
• ANTERO-5: Gastric Motility in Postoperative Ileus
  “Inadequate recruitment due to COVID-19 restrictions.” (85% match in meaning)
• Evaluating MyPath to Enhance Reproductive Autonomy and Liberate Decision-making
  “Recruitment hindered by COVID-19 pandemic, unable to recruit participants virtually” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.